Evidence map›Paper›PMID 38504381›Full record

ArticleOne health outlook2024

Assessing One Health capacities for transboundary zoonotic diseases at the Libya-Tunisia border.

Lauren N Miller, Walid K Saadawi, Wafa Ben Hamouda, Ahmed S Elgari, Emaduldin A Abdulkarim, Ashur M M Lmrabet, Abir E Elbukhmari, Kaouther Harabech, Ammar Ali Jemai, Milad Farhat and 6 more

Abstract read
In one paragraph

Article in One health outlook, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Lauren N Miller *Center for Global Health Science and Security, Georgetown University Medical Center, Washington, DC, USA.
Walid K Saadawi *National Centre for Disease Control, Tripoli, Libya.
Wafa Ben Hamouda *General Directorate for Veterinary Services, Ministry of Agriculture, Water Resources and Fisheries, Tunis, Tunisia.
Ahmed S ElgariNational Centre for Disease Control, Tripoli, Libya.
Emaduldin A AbdulkarimNational Centre for Animal Health, Tripoli, Libya.
Ashur M M LmrabetNational Centre for Disease Control, Tripoli, Libya.
Abir E ElbukhmariNational Centre for Disease Control, Tripoli, Libya.
Kaouther HarabechMinistry of Public Health, Tunis, Tunisia.
Ammar Ali JemaiCDRA, Ministry of Agriculture, Water Resources and Fisheries, Tunis, Tunisia.
Milad FarhatNational Centre for Animal Health, Tripoli, Libya.
Rasha Al-AzabEastern Mediterranean Public Health Network, Amman, Jordan.
Abdulaziz ZorganiNational Centre for Disease Control, Tripoli, Libya.
Omar ElamherNational Centre for Disease Control, Tripoli, Libya.
Tarek Al SanouriEastern Mediterranean Public Health Network, Amman, Jordan.
Claire J StandleyCenter for Global Health Science and Security, Georgetown University Medical Center, Washington, DC, USA.
Erin M SorrellCenter for Health Security, Department of Environmental Health and Engineering, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA. esorrell@jhu.edu.ORCID http://orcid.org/0000-0003-2456-4540

Funding

U.S. Department of State S-ISNCT-20-CA-0035
6 · The paper itself

Abstract

backgroundThe dynamic nature of zoonotic emergence, spillover and spread necessitates multisectoral coordination beyond national borders to encompass cross-boundary and regional cooperation. Designated points of entry (POEs), specifically ground crossings, serve as critical locales for establishing and maintaining robust prevention, detection, notification, coordination, and response mechanisms to transboundary emerging and re-emerging disease threats. In order to better assess One Health capacities for transboundary zoonotic diseases (TZD) prevention, detection and response we adapted an existing tool, One Health Systems Assessment for Priority Zoonoses (OHSAPZ), for a cross-border, POE setting in North Africa.

methodsThe One Health Transboundary Assessment for Priority Zoonoses (OHTAPZ) tool was used to support prioritization of transboundary zoonoses and analyze operational capacities between national and subnational-level human and animal health stakeholders from Libya and Tunisia. Country partners jointly identified and prioritized five TZDs of concern. Case study scenarios for each priority pathogen were used to elicit current disease operations, as well as multisectoral and bilateral engagement networks. Finally, a gap analysis was performed to determine bilateral strengths and weaknesses to TZDs.

resultsThe five priority TZDs jointly confirmed to undergo One Health assessment were avian influenza (low and high pathogenic strains); brucellosis; Rift Valley fever; Crimean-Congo hemorrhagic fever; and rabies. Using the qualitative information collected, a transboundary systems map schematic was developed outlining the movement of human patients, animals, diagnostic samples, and routes of communication and coordination both within and between countries for zoonotic diseases.

conclusionsAnalysis of current operations (prevention, detection, surveillance, laboratory capacity, quarantine/isolation, and response) and the resulting transboundary systems map schematic helped identify existing capacity strengths for certain priority pathogens, as well as challenges to timely information-sharing and coordination. We developed targeted recommendations to address these limitations for joint action planning between Libya and Tunisia.

Indexed as

Cross-border collaborationDisease prioritization toolsEmerging infectious diseasesGround crossingMultisectoral engagementOne healthPoints of entryTransboundary zoonotic diseases

Identifiers

PMID38504381
PMCPMC10953064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.